Plougmann Vingtoft Blocks Inventors' Chemo Response IP
By Hanna Vioque ( November 7, 2025, 7:09 PM GMT) -- IP consulting firm Plougmann Vingtoft has convinced European appellate officials to nix a group of inventors' patented method to determine if a cancer patient is responsive to chemotherapy. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.